These compounds may interact with:
Acetyl-CoA carboxylase 2
Potentially involved in: endometrial cancer; breast cancer; kidney cancer; carcinoma; biotin deficiency; obesity; diabetes mellitus; glycogen storage disease v; insulin resistance; astrocytoma, pilocytic; breast carcinoma; colon cancer; dermatomyositis; ductal carcinoma in situ; group 3 medulloblastoma; invasive ductal carcinoma; lung adenocarcinoma; lung cancer; malignant mesothelioma; medulloblastoma, large-cell
Disease data sourced from Pharos.